We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+15.41%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.93B
AUM Growth
+$1.24B
(+22%)
Cap. Flow
+$454M
Cap. Flow
% of AUM
6.54%
Top 10 Holdings %
Top 10 Hldgs %
16.4%
Holding
1,110
New
146
Increased
497
Reduced
266
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVR
NVR
|
+$34.9M |
| 2 |
SBA Communications
SBAC
|
+$31.5M |
| 3 |
Lennox International
LII
|
+$29.1M |
| 4 |
McKesson
MCK
|
+$24.8M |
| 5 |
Cable One
CABO
|
+$23.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.8M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$52.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$42.5M |
| 4 |
Intuitive Surgical
ISRG
|
+$35.5M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.87% |
| 2 | Financials | 16.58% |
| 3 | Consumer Discretionary | 13.8% |
| 4 | Industrials | 12.36% |
| 5 | Healthcare | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALDR
626
DELISTED
Alder Biopharmaceuticals
ALDR
| $1.17M | 0.02% |
85,625
+40,100
| +88% | +$520K |
|
627
Travelzoo
TZOO
$105M
| $1.16M | 0.02% |
86,359
+26,068
| +43% | +$345K |
|
628
Zumiez
ZUMZ
$328M
| $1.15M | 0.02% |
46,120
+3,000
| +7% | +$71.1K |
|
|
FSP
629
Franklin Street Properties
FSP
$45.7M
| $1.13M | 0.02% |
157,718
+10,600
| +7% | +$76.1K |
|
|
XHR
630
Xenia Hotels & Resorts
XHR
$2B
| $1.13M | 0.02% |
51,534
+6,100
| +13% | +$116K |
|
|
QTS
631
DELISTED
QTS REALTY TRUST, INC.
QTS
| $1.12M | 0.02% |
24,944
-35,705
| -59% | -$1.49M |
|
|
PRNB
632
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $1.12M | 0.02% |
+32,845
| New | +$1.04M |
|
633
Voyager Therapeutics
VYGR
$187M
| $1.11M | 0.02% |
+58,145
| New | +$757K |
|
634
IMAX
IMAX
$2.47B
| $1.11M | 0.02% |
49,026
-1,700
| -3% | -$36.3K |
|
635
STAAR Surgical
STAA
$1.14B
| $1.11M | 0.02% |
32,502
+10,000
| +44% | +$354K |
|
|
AD
636
Array Digital Infrastructure
AD
$2.99B
| $1.1M | 0.02% |
24,010
-2,218
| -8% | -$116K |
|
|
AVYA
637
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $1.1M | 0.02% |
65,440
-651,836
| -91% | -$10.2M |
|
|
GTS
638
DELISTED
Triple-S Management Corporation
GTS
| $1.1M | 0.02% |
50,730
+23,903
| +89% | +$486K |
|
639
Universal Logistics Holdings
ULH
$376M
| $1.1M | 0.02% |
55,745
+18,500
| +50% | +$384K |
|
640
Inspire Medical Systems
INSP
$1.47B
| $1.09M | 0.02% |
+19,200
| New | +$1.04M |
|
641
Celanese
CE
$4.87B
| $1.09M | 0.02% |
11,040
-50,110
| -82% | -$4.93M |
|
642
iShares Russell 2000 Growth ETF
IWO
$14.4B
| $1.08M | 0.02% |
5,480
+150
| +3% | +$28.5K |
|
643
First American
FAF
$7.79B
| $1.07M | 0.02% |
20,800
+320
| +2% | +$15.9K |
|
644
Kroger
KR
$35.5B
| $1.06M | 0.02% |
+43,140
| New | +$1.18M |
|
|
UCB
645
United Community Banks
UCB
$4.21B
| $1.06M | 0.02% |
42,540
-1,070
| -2% | -$27.8K |
|
646
Axsome Therapeutics
AXSM
$12.3B
| $1.06M | 0.02% |
74,265
-9,900
| -12% | -$91.9K |
|
647
Sierra Bancorp
BSRR
$538M
| $1.05M | 0.02% |
43,422
+6,950
| +19% | +$180K |
|
|
RAD
648
DELISTED
Rite Aid Corporation
RAD
| $1.05M | 0.02% |
+82,877
| New | +$1.28M |
|
|
HMHC
649
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $1.05M | 0.02% |
144,906
+123,640
| +581% | +$1.11M |
|
650
Synopsys
SNPS
$74.5B
| $1.05M | 0.02% |
9,110
-280,023
| -97% | -$27.7M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2019 Portfolio in Review
As of Q1 2019, Jacobs Levy Equity Management held 1,110 positions worth $6.93B, up 22% from $5.69B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Jacobs Levy Equity Management deployed $454M of net new capital in Q1 2019, opening 146 new positions and adding to 497 existing holdings. Its largest new stake was AbbVie: 282,010 shares worth $22.7M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $52.7M trimmed.
- Jacobs Levy Equity Management's largest Q1 2019 buy was AbbVie: 282,010 shares worth $22.7M.
- Jacobs Levy Equity Management added most to NVR in Q1 2019, an estimated $34.9M increase.
- Jacobs Levy Equity Management's biggest Q1 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $52.7M.
- Jacobs Levy Equity Management fully exited Celgene Corp in Q1 2019, selling an estimated $55.8M.
- Jacobs Levy Equity Management's ten largest holdings make up 16% of its $6.93B portfolio in Q1 2019.
- Jacobs Levy Equity Management opened 146 new positions and closed 160 in Q1 2019.
- Jacobs Levy Equity Management's portfolio value rose 22% quarter-over-quarter to $6.93B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2019, filed 14 May 2019.